Lumpectomy Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Lumpectomy Market Size

Lumpectomy Market size is expected to experience a significant expansion from 2024 to 2032, driven by the surging prevalence of breast cancer worldwide. As per NBCF.org, in 2023, it was projected that around 297,790 women and 2,800 men received a diagnosis of invasive breast cancer. There is a strong support from government, leading to an increased number of awareness programs focused on breast cancer. 
 

Growing preference for the procedure over other radial surgeries, in tandem with the emergence of novel and better breast cancer imaging methods, including 3D tomography, will propel the industry gains. There is a growing emphasis on the utilization of advanced imaging technologies in preoperative planning for lumpectomies. The integration of these technologies enhances the surgeon’s ability to achieve optimal tumor excision while minimizing damage to healthy breast tissue.
 

Lumpectomy Market Trends

One significant trend is the increasing adoption of oncoplastic techniques in lumpectomy procedures. Oncoplastic surgery combines the principles of oncology and plastic surgery, allowing for more extensive tumor removal while preserving the natural appearance of the breast.
 

The ongoing supply chain constraints caused because of the ongoing disturbances between Ukraine and Russia and restricted global trade flows may lead to a significant rise in commodity prices. This may worsen the rate of inflation globally and may reduce consumer spending capacity while limiting healthcare expenditure.
 

Lumpectomy Market Analysis

Lumpectomy systems segment is slated to account for a considerable gains by 2032, owing to the increased adoption of these systems by surgeons during lumpectomy procedures. On the other hand, the preference for lumpectomy surgical tools will grow with the influx of several technological innovations focused on limiting the increasing instances of breast cancer operations.
 

Ambulatory surgical centers (ASC) segment is anticipated to rise through 2032. Many women prefer undergoing breast cancer treatment and surgeries across these facilities considering their higher popularity in multiple tertiary centers. ASCs are touted as safe and economical substitutes for inpatient admission and offer a more effective utilization of healthcare resources and early discharge.
 

North America lumpectomy market size is projected to expand substantially throughout 2024-2032, attributed to the strong presence of venture capitalists in the country. The growing prevalence of breast cancer largely among American women, boosts product demand. As per CDC, every year about 240,000 women and about 2,100 in men suffer from breast cancer. Factors such as rising technological advancements, improved healthcare infrastructure, and increasing R&D funds for conducting clinical trials.
 

Lumpectomy Market Share

The lumpectomy industry is highly competitive and comprises the leading players:

• Focal Therapeutics Inc.
• Novian Health Inc.
• Vector Surgical LLC
• Cianna Medical
• Endomagnetics Ltd.
• ClearCut Medical
• Dune Medical Devices
• iCAD Inc.
• Carl Zeiss Meditec AG
• Ranfac Corporation
• Hologic Inc.
• Theragenics

Lumpectomy Industry News

• In September 2023, Hologic Inc. and Bayer partnered to deliver contrast-enhanced mammography solutions for improving the detection of breast cancer for women in multiple countries across the Canadian, European, and Asia Pacific regions.

What Information does this report contain?